News

Nektar Therapeutics Stock Doubles After Promising Eczema Drug Trial Results
Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...
Stocktwits on MSN29m
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further
Shares of Nektar Therapeutics (NKTR) more than doubled on Tuesday afternoon after the company announced that its mid-stage ...
Nektar Therapeutics' experimental eczema drug meets main goal of mid-stage trial
Nektar Therapeutics said on Tuesday its experimental eczema drug had met the main goal of a mid-stage study. In the 393-patient trial, drug candidate rezpegaldesleukin showed a reduction in the ...
Nektar Therapeutics' experimental eczema drug meets main goals of mid-stage trial
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...